Could vitamin d help kids with Graves' disease? new trial launches
NCT ID NCT07369063
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study tests whether adding high-dose vitamin D to standard methimazole therapy helps control thyroid function and antibodies in children aged 9-17 newly diagnosed with Graves' disease. The main goal is to see if a larger trial is possible by measuring recruitment, adherence, and data quality. Thirty participants will be randomly assigned to receive either vitamin D or a placebo alongside their usual medication.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GRAVES DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Pediatric Endocrinology at Northwell Health
RECRUITINGNew Hyde Park, New York, 11042, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Hidden thyroid cancers may be more common in Graves' disease than thought
- Can a steroid shot make thyroid surgery safer?
- Smart wristband may spot thyroid drug imbalances before blood tests do
- Targeting the immune system: a new antibody may free Graves' patients from daily drugs
- AI reads eye scans to spot thyroid disease activity and severity
- Foot flex could tame cholesterol and blood sugar